Quest Diagnostics Executive Compensation
Quest Diagnostics is a publicly traded company in the Healthcare sector.
Named Executive Officers — FY2024
Compensation Analysis
Computed directly from SEC-sourced figures tracked on this page — not a general description.
Quest Diagnostics discloses FY2024 compensation for 5 named executive officers, totaling $26.0M. James E. Davis, the Chairman, accounts for 54% of that combined total.
James E. Davis's total compensation rose 939% year-over-year, from $1.4M in FY2023 to $14.1M in FY2024.
Cash compensation (salary plus bonus) made up 14% of Quest Diagnostics's FY2024 tracked executive pay, with stock awards accounting for 72%. That's notably more stock-weighted than the typical Healthcare company in this dataset, where stock awards average 0% of tracked pay.
Among 78 other Healthcare companies in this dataset, Quest Diagnostics's combined tracked executive pay of $26.0M ranks in the 78th percentile (industry median: $12.5M). Its highest-paid executive, James E. Davis, ranks in the 71th percentile for top-executive pay in the sector (industry median: $6.0M).